Navigation Links
Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
Date:9/17/2008

- ORACLE MS Phase III Trial Will Assess Effectiveness of Cladribine Tablets in Preventing Conversion to Definite Multiple Sclerosis in Addition to the

Fully Enrolled Phase III Pivotal Trial -

- the CLARITY Study -

- for Treatment of Relapsing Forms of Multiple Sclerosis

GENEVA, Sept. 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the initiation of a Phase III trial to evaluate the therapeutic effects of its proprietary oral formulation of Cladribine (Cladribine tablets) in patients at risk of developing multiple sclerosis (MS).

The trial, called ORACLE MS (Oral Cladribine in Early MS) will evaluate the safety and efficacy of two dosage regimens of Cladribine tablets versus placebo in the treatment of patients who have experienced a first clinical event suggestive of MS. Cladribine tablets are currently also being evaluated in a fully enrolled Phase III pivotal trial - the CLARITY(1) study -- for treatment of relapsing forms of MS. As announced in January 2007, CLARITY was the first pivotal trial among all Phase III oral compounds in development for MS to complete enrollment. Cladribine tablets have been granted a fast track designation by the US Food and Drug Administration.

"There is increasing evidence supporting the initiation of treatment with a disease-modifying drug in patients who have experienced a first clinical event suggestive of multiple sclerosis, an initial stage of the disease when clinical manifestations are not necessarily pronounced but where the potential exists for irreversible neurological damage to take place," said Dr. Thomas Leist, Associate Professor of Neurology and Director of the Comprehensive MS Center at Thomas Jefferson University, Philadelphia, PA, and an investigator in the ORACLE MS study. "The ORACLE MS study will evaluate the effectiveness and safety of Cladribine tablets in preventing conversion to
'/>"/>

SOURCE Merck Serono International S A
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
4. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
5. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
6. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
7. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
8. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
9. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
10. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
11. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Minn. , Aug. 1, 2014 ... medical technologies company, announced today that it has ... held manufacturer of cardiorespiratory diagnostic products based in ... MediSoft has served the European cardiorespiratory diagnostics market ... 2013 revenues of approximately €4.7 million ($6.3 million) ...
(Date:8/1/2014)... 1, 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: ... technologies are used to develop, manufacture and sell enzymes ... and industrial enzyme industries, announced today that it will ... June 30, 2014 after market close on Thursday, August ... day at 5:00 p.m. Eastern Time to discuss those ...
(Date:7/31/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... , Chief Business Officer and Executive Vice President. Mr. Singh ... 30. "Sorrento is deeply saddened and shocked by ... thoughts go to Amar,s family and friends," said Henry ... Mr. Singh joined Sorrento in January 2014 from ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2
... Oct. 8 Breast-Specific Gamma Imaging (BSGI), a molecular ... resonance imaging (MRI) for detecting breast carcinoma when used ... and is substantially less expensive than MRI, according to ... Oncology Breast Cancer Symposium in San Francisco, California. , ...
... Calif., Oct. 8 Endologix, Inc. (Nasdaq: ELGX ), ... that it has become aware that Cook Medical has filed ... alleging that Endologix infringes two of Cook,s U.S. patents. , ... have just become aware of the lawsuit filed by Cook ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis 2Endologix Comments on Alleged Patent Infringement 2
(Date:8/1/2014)... 2014 St. Christopher's Hospital for Children ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , St. Christopher's Hospital for Children offers ... from birth through 21 years of age. With over ... hospital's specialties, including autism and childhood obesity. , ...
(Date:8/1/2014)... August 01, 2014 Narconon Arrowhead recently ... program at the drug rehab center located in the ... 2001, Narconon Arrowhead is the flagship drug rehab center ... the United States for services there. Now, with such ... recent outcome studies as well as client reviews showing ...
(Date:8/1/2014)... Arlington, TX (PRWEB) August 01, 2014 ... of the Year for its outstanding commitment to St. ... for the hospital since 1999 and pledging to raise ... to combat childhood cancer and other deadly diseases. ... from any single partner in St. Jude history. Specifically, ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, 2014 ... of heart attack and stroke, particularly if you work in ... officials reported Thursday. But being unemployed might be just ... include job stress, exposure to air pollution -- like dust ... Sara Luckhaupt, from the National Institute for Occupational Safety and ...
(Date:8/1/2014)... 01, 2014 For the first time, ... Cotton Farm & Fiber Report and the Organic Cotton ... entire organic cotton supply chain resulting in the ... organization’s Managing Director, reports, “We are looking holistically at ... the beginning of a long value chain and surveying ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 3Health News:St. Jude Children’s Research Hospital® Names Tri Delta Fraternity Partner of the Year 2Health News:St. Jude Children’s Research Hospital® Names Tri Delta Fraternity Partner of the Year 3Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Surveys Reveal the Top 10 Organic Cotton Users and the Top 10 Producing Countries 2
... ... shows vacations with animals will help the family bond. Spending quality time with the family often ... ... families are finding it exciting and different to spend their vacations at a Dude or Guest ...
... ... Legal Hold Pro™ service into doeDiscovery™. Further expanding doeLegal,s capabilities across the entire spectrum ... to offer increased value to all eDiscovery clients. , ... (PRWEB) May 14, 2010 -- doeLegal, ...
... essays look at ethical issues arising from new neuroimaging ... severe brain injury might be able to communicate. ... Authors: J. Andrew Billings, Larry R. Churchill, and Richard ... or a meaningful existence? The authors contend that ...
... ... luminaries in science , ... New York, NY (Vocus) May 13, 2010 -- Mount Sinai School of Medicine ... field of genetics and human genome research, and renowned humanists whose work has advanced ...
... Recognizing ... by cancer, CIGNA expands access to all Cancer Treatment Centers of America physicians and facilities. ... Chicago, IL (PRWEB) May ... customers who have been touched by cancer, CIGNA has entered into a new agreement that ...
... affects 1 in 20 people over age 65, experts ... By treating the common irregular heartbeat known as atrial ... prevent Alzheimer,s disease and other forms of dementia, new ... of the heart beat chaotically, causing blood to pool ...
Cached Medicine News:Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 2Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 3Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 4Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 2Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 3Health News:The Hastings Center Report table of contents for May/June 2010 2Health News:The Hastings Center Report table of contents for May/June 2010 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 2Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 4Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 5Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 6Health News:CIGNA and Cancer Treatment Centers of America Reach New Agreement 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 3
The Reusable Purse String Clamp is intended for use in the mechanical construction of a purse string suture. The clamp can be used on any part of the gastrointestinal tract except the esophagus....
... VALTRAC™ Single Use Biofragmentable Anastomosis ... end-to-end, end-to-side and side-to-side anastomosis., ... and multiple intestinal anastomoses but not ... device may be used in any ...
The Auto Suture™ EEA™ 34mm reusable stainless steel sizer has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
... in the parafollicular C-cells of the thyroid ... The major action of calcitonin is to ... activity, resulting in decreased mobilization of calcium ... evident in conditions associated with high levels ...
Medicine Products: